24 . 04 .2026
News story
Understanding connections across inflammatory skin conditions: the SKIN approach
23 . 04 .2026
Press release
Galderma reports strong start to the year, delivering first quarter 2026 net sales of 1.473 billion USD, growing 25.5% at constant currency
22 . 04 .2026
Press release
Galderma shareholders approve all Annual General Meeting proposals
16 . 04 .2026
Press release
Galderma launches new Alastin Regenerating Skin Nectar with TriHex+™, powered by its next-generation TriHex Technology® regenerative platform
09 . 04 .2026
Press release
Interim data from two ongoing investigator-initiated trials highlight the role of Sculptra® and Restylane® in addressing aesthetic changes associated with weight loss medications and menopause
07 . 04 .2026
Press release
Galderma debuts ALASTIN Signature Practices in partnership with leading aesthetic practices to elevate regenerative, peri-procedural skincare
28 . 03 .2026
Press release
AAD 2026: Late-breaking nemolizumab data demonstrate clinically meaningful benefits for children aged 2 to 11 with moderate-to-severe atopic dermatitis
24 . 03 .2026
Press release
AAD 2026: Galderma showcases latest evidence supporting its full-spectrum, science-driven solutions for diverse skin needs
23 . 03 .2026
Press release
Galderma receives U.S. FDA approval for Restylane® Contour™ for the correction of temple hollowing
